NC H621

Requires the North Carolina Commission for Public Health to confirm that any new vaccine added to the state's childhood immunization schedule has been FDA-approved for a minimum of three years before implementation

Allows the Commission to add an FDA-approved vaccine with less than three years of approval only upon recommendation by both the North Carolina Medical Society Board of Directors and the North Carolina Pediatric Society Board of Directors

Applies to new vaccine requirements established for children in the state on or after the bill's effective date

Modifies existing immunization requirements in G.S. 130A-152 to add the three-year FDA approval confirmation requirement as a condition for adding diseases beyond those currently required (diphtheria, tetanus, whooping cough, poliomyelitis, measles, and rubella)